The 50-year-old was later diagnosed with third stage colon cancer in
February. Having undergone surgery earlier this year, she was then
prescribed six sessions of chemotherapy.
But with shortages of basic goods plaguing every aspect of Lebanese
life, Tohme was told there was no guarantee she would complete her
treatment as hospitals run out of vital drugs.
So far she has only undergone three sessions. Her cancer has
metastasized to her lymph nodes and she fears if she cannot complete
her treatment she will only have months to live.
Having knocked on every door to try to secure her medication at any
cost, Tohme took to the streets on Thursday, despite her ailing
health, to join a sit-in protest with other cancer patients, doctors
and non-governmental organisations.
"I'm hoping that God gives me strength, as I don't have that much,
to stand on my two feet and take part so that maybe people will see
us and sympathise with us and send us treatment," Tohme told Reuters
two days before the event.
"I have kids, I want to be happy with them and see them get married
and become a grandmother."
Lebanese healthcare workers have warned for months of declining
stocks of vital medical supplies. Many pharmacy shelves are empty as
the country's foreign reserves are depleted on the back of a subsidy
scheme used to finance fuel, wheat and medicine that cost the state
around $6 billion a year.
This month the central bank declared it could no longer finance fuel
imports at subsidised exchange rates because its dollar reserves had
been so badly depleted.
CANCER HAS NO PATIENCE
Tohme's case is not unique. Dr. Joseph Makdessi, who heads the
haematology and oncology department at the Saint George Hospital
University Medical Centre, estimates around 10% of cancer patients
have been unable to source their treatment in the past couple of
months.
"We need an immediate solution," Makdessi said. "I can't tell my
patients this is a crisis and ask them to wait till it eases because
this disease has no patience."
Lebanon's deeply indebted state is struggling to raise funds from
abroad amidst political paralysis and has gradually eradicated many
subsidies.
[to top of second column] |
But cancer medications are
still subsidised, meaning in order for agents to
import them they have to wait for financing from
the central bank, which has all but run down its
reserves.
Yet Dr. Makdessi isn't optimistic that easing
subsidies on cancer drugs will solve his
patients' pressing problem.
Some chemotherapy treatments, which can cost as
much as $5,000 per session, are currently
subsidized so the patient pays around $400, with
the state bearing the rest of the cost.
"Even if you lift this subsidy to make the medication available,
many patients won't be able to afford it," he said.
The health ministry did not immediately respond to a request for
comment.
Caretaker Health Minister Hamad Hassan, who has been raiding depots
storing large quantities of drugs and medical supplies, partly
blamed the shortages on traders hoarding supplies.
The Barbara Nassar Association for Cancer Patient Support, the
Lebanese advocacy group that organised Thursday's sit-in, has
provided medication worth more than $1.5 million in 2020 through
in-kind donations from former patients.
But now Hani Nassar, whose wife Barbara founded the organisation
before passing away from the disease years ago, says the country's
fractious politics is hampering efforts to alleviate the problem.
"The central bank wants to remove the subsidy and the health
ministry doesn't and in the meantime the patient is sitting there
without treatment," Nassar said.
At Thursday's sit-in, patients said they were reaching out to
whoever could help them get a second chance at life.
"After all I endured, I lost my nails and hair and my body changed,
now I reached this point of not finding the treatment and this
really set me back," engineer Bahaa Costantine said.
"I was a person who was full of energy and loves life, I don't want
to be a bride for heaven, this is what I refuse. I hope my voice
reaches someone who can help."
(Reporting By Maha El Dahan, Alaa Kanaan and Issam Abdallah; Editing
by Alex Richardson)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |